To clarify the link between autoimmune disease and hypercholesterolemia, we created the gld.apoE−/− mouse as a model of accelerated atherosclerosis. Atherosclerotic lesion area was significantly increased in gld.apoE−/− mice compared with apoE−/− mice. gld.apoE−/− mice also displayed increases in lymphadenopathy, splenomegaly, and autoantibodies compared with gld mice, and these effects were exacerbated by high cholesterol diet. gld.apoE−/− mice exhibited higher levels of apoptotic cells, yet a reduced frequency of engulfed apoptotic nuclei within macrophages. Infusion of lysophosphatidylcholine, a component of oxidized low density lipoprotein, markedly decreased apoptotic cell clearance in gld mice, indicating that hypercholesterolemia promotes autoimmune disease in this background. These data suggest that defects in apoptotic cell clearance promote synergy between atherosclerotic and autoimmune diseases.
Skip Nav Destination
Article navigation
19 April 2004
Article Contents
Article|
April 19 2004
Impaired Clearance of Apoptotic Cells Promotes Synergy between Atherogenesis and Autoimmune Disease
Tamar Aprahamian,
Tamar Aprahamian
1Molecular Cardiology, Whitaker Cardiovascular Institute
3Department of Anatomy and Cellular Biology, Program in Cellular, Molecular, and Developmental Biology, Tufts University School of Medicine, Boston, MA 02111
Search for other works by this author on:
Ian Rifkin,
Ian Rifkin
2Renal Section, Department of Medicine, Boston University School of Medicine, Boston, MA 02118
Search for other works by this author on:
Ramon Bonegio,
Ramon Bonegio
2Renal Section, Department of Medicine, Boston University School of Medicine, Boston, MA 02118
Search for other works by this author on:
Bénédicte Hugel,
Bénédicte Hugel
4Institut d'Hématologie et d'Immunologie, Faculté de Médecine, Université Louis Pasteur, 67085 Strasbourg et Institut National de la Santé et de la Recherche Médicale, U143, 94276 Le Kremlin-Bicetre, France
Search for other works by this author on:
Jean-Marie Freyssinet,
Jean-Marie Freyssinet
4Institut d'Hématologie et d'Immunologie, Faculté de Médecine, Université Louis Pasteur, 67085 Strasbourg et Institut National de la Santé et de la Recherche Médicale, U143, 94276 Le Kremlin-Bicetre, France
Search for other works by this author on:
Kaori Sato,
Kaori Sato
1Molecular Cardiology, Whitaker Cardiovascular Institute
Search for other works by this author on:
John J. Castellot, Jr.,
John J. Castellot, Jr.
3Department of Anatomy and Cellular Biology, Program in Cellular, Molecular, and Developmental Biology, Tufts University School of Medicine, Boston, MA 02111
Search for other works by this author on:
Kenneth Walsh
Kenneth Walsh
1Molecular Cardiology, Whitaker Cardiovascular Institute
3Department of Anatomy and Cellular Biology, Program in Cellular, Molecular, and Developmental Biology, Tufts University School of Medicine, Boston, MA 02111
Search for other works by this author on:
Tamar Aprahamian
1Molecular Cardiology, Whitaker Cardiovascular Institute
3Department of Anatomy and Cellular Biology, Program in Cellular, Molecular, and Developmental Biology, Tufts University School of Medicine, Boston, MA 02111
Ian Rifkin
2Renal Section, Department of Medicine, Boston University School of Medicine, Boston, MA 02118
Ramon Bonegio
2Renal Section, Department of Medicine, Boston University School of Medicine, Boston, MA 02118
Bénédicte Hugel
4Institut d'Hématologie et d'Immunologie, Faculté de Médecine, Université Louis Pasteur, 67085 Strasbourg et Institut National de la Santé et de la Recherche Médicale, U143, 94276 Le Kremlin-Bicetre, France
Jean-Marie Freyssinet
4Institut d'Hématologie et d'Immunologie, Faculté de Médecine, Université Louis Pasteur, 67085 Strasbourg et Institut National de la Santé et de la Recherche Médicale, U143, 94276 Le Kremlin-Bicetre, France
Kaori Sato
1Molecular Cardiology, Whitaker Cardiovascular Institute
John J. Castellot, Jr.
3Department of Anatomy and Cellular Biology, Program in Cellular, Molecular, and Developmental Biology, Tufts University School of Medicine, Boston, MA 02111
Kenneth Walsh
1Molecular Cardiology, Whitaker Cardiovascular Institute
3Department of Anatomy and Cellular Biology, Program in Cellular, Molecular, and Developmental Biology, Tufts University School of Medicine, Boston, MA 02111
Address correspondence to Kenneth Walsh, Molecular Cardiology, Whitaker Cardiovascular Institute, Boston University School of Medicine, 715 Albany St., W611, Boston, MA 02118. Phone: (617) 414-2392; Fax: (617) 414-2391; email: [email protected]
Abbreviations used in this paper: aCL, anticardiolipin antibody; ANA, antinuclear antibody; LDL, low density lipoprotein; LPC, lysophosphatidylcholine; oxLDL, oxidized LDL; TUNEL, TdT-mediated dUTP nick-end labeling; VLDL, very LDL.
Received:
September 10 2003
Accepted:
March 04 2004
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2004
J Exp Med (2004) 199 (8): 1121–1131.
Article history
Received:
September 10 2003
Accepted:
March 04 2004
Citation
Tamar Aprahamian, Ian Rifkin, Ramon Bonegio, Bénédicte Hugel, Jean-Marie Freyssinet, Kaori Sato, John J. Castellot, Kenneth Walsh; Impaired Clearance of Apoptotic Cells Promotes Synergy between Atherogenesis and Autoimmune Disease . J Exp Med 19 April 2004; 199 (8): 1121–1131. doi: https://doi.org/10.1084/jem.20031557
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement